PROFESSIONAL EDUCATION
• Taipei Medical College in Medicine
• Graduate Institute of Pathology, College of Medicine, National Taiwan University with M.S. degree
• Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University with Ph.D. degree,
ADMINSTRATIVE APPOINTMENTS
• Attending Physician, Department of Pathology, Taipei Medical University Hospital
• Associate Professor, Department of Pathology, Taipei Medical University
PUBLICATIONS
1. Lee YC, Lin SC, Yu G, Cheng CJ, Liu B, Liu HC, Hawke DH, Parikh NU, Varkaris A, Corn P, Logothetis C, Satcher RL, Yu-Lee LY, Gallick GE, Lin SH. Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer. Cancer Res., 2015; 75(22):4949-59.
2. Chatterji T, Varkaris AS, Parikh NU, Song JH, Cheng CJ, Schweppe RE, Alexander S, Davis JW, Troncoso P, Friedl P, Kuang J, Lin SH, Gallick GE. Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells. Oncotarget, 2015; 6(12):10175-94.
3. *Yu G, *Lee YC, *Cheng CJ, Wu CF, Song JH, Gallick GE, Yu-Lee LY, Kuang J, Lin SH. RSK Promotes Prostate Cancer Progression in Bone through ING3, CKAP2 and PTK6-mediated Cell Survival. Mol Cancer Res, 2015; 13(2):348-57.
4. Jin JK, Tien PC, Cheng CJ, Song JH, Huang C, Lin SH, Gallick GE. Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis.. Oncogene, 2015; 34(14):1811-21.
5. *Lee YC, *Jin JK, *Cheng CJ, Huang CF, Song JH, Huang M, Brown WS, Zhang S, Yu-Lee LY, Yeh ET, McIntyre BW, Logothetis CJ, Gallick GE, Lin SH. (2013, Apr). Targeting Constitutively Activated β1 Integrins Inhibits Prostate Cancer Metastasis. Mol Cancer Res, 2013;11(4):405-417.
6. Lee YC, Cheng CJ, Bilen MA, Lu JF, Satcher RL, Yu-Lee LY, Gallick GE, Maity SN, Lin SH. BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Res, 2011; 71(15):5194-203.
7. Lin YC, Chen CC, Cheng CJ, Yang RB (2011, Jul). Domain and functional analysis of a novel breast tumor suppressor protein, SCUBE2. J Biol Chem. 286(30):27039-47.